The rare missense mutation (rs75932628-T) in TRME2, which was predicted to result in R47H substitution, was found to confer AD risk (odds ratio, 2.92) with an effect size that is similar to that of APOE ε4 [120]. This evidence concerns the gene APOE and Alzheimer disease.